Cardiologists just rewrote the rulebook on cholesterol. In March 2026, the American College of Cardiology (ACC) and American Heart Association (AHA), along with nine other leading medical groups, released updated guidelines that reshape how doctors evaluate and treat cholesterol risk.
Here’s what changed, and why experts are calling it a genuine shift in how heart disease prevention works.
Why Did the Guidelines Change?
This is the first major update since 2018. Cholesterol guidelines don’t follow a fixed schedule. Instead, they get revised when new research points to a better way to catch risk early and prevent disease.
The new guideline retires and replaces the 2018 version entirely. It’s officially titled the “2026 Guideline on the Management of Dyslipidemia,” a broader term covering cholesterol, triglycerides, and other blood lipids, not just LDL.
The stakes are significant. An estimated 1 in 4 U.S. adults has high LDL cholesterol, which raises the risk of heart attack and stroke.
New LDL Targets, Tailored by Risk Level
The guidelines now set three separate LDL cholesterol targets, based on individual risk:
90 mg/dL for people without existing cardiovascular disease
70 mg/dL for people with significant risk factors
55 mg/dL for people at the highest risk
One cardiologist involved in the update called it a genuine “paradigm shift,” since the guidance now pushes for lower targets sustained over a longer stretch of a person’s life, rather than treating cholesterol as a problem to manage later in adulthood.
Cholesterol Screening Now Starts Earlier
The new guidelines apply to people as young as 30. That’s a notable shift toward catching risk decades before a heart attack or stroke might occur.
Doctors now also assess risk two ways: a traditional 10-year risk estimate, plus a newer 30-year risk assessment. That longer window helps identify people who look low-risk in the short term but carry meaningful risk over their lifetime.
Even childhood matters now. The guidelines specifically note how high cholesterol during childhood and adolescence affects heart disease risk later in life, and support earlier lifestyle intervention starting young.
A New Blood Test Enters the Picture
The guidelines recommend a one-time screening for lipoprotein(a), or Lp(a), a genetic risk factor most people have never heard of. Unlike LDL, Lp(a) levels are largely determined by genetics rather than diet or lifestyle, which makes a single early test valuable for uncovering hidden risk that routine cholesterol panels can miss.
Lifestyle Still Comes First
Despite all the new numbers and tests, the guidelines lead with the basics:
Avoiding tobacco products
Regular physical activity
Healthy sleep habits
Maintaining a healthy weight
Cholesterol-lowering medication, when a doctor prescribes it
Medication comes into play earlier for specific groups, too. That includes young adults with LDL levels of 160 mg/dL or higher, people with a strong family history of heart disease, and anyone with a genetic condition called familial hypercholesterolemia.
Bottom Line
This update marks the biggest change to cholesterol guidance in nearly a decade. Lower LDL targets, earlier screening starting at 30, a new genetic risk test, and a longer-term view of cardiovascular risk all point toward the same goal: catching heart disease risk years, sometimes decades, before it becomes a heart attack or stroke. For more health explainers like this, check out [our latest health coverage] on the site.
